Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic comparison of thienopyridine loading strategies in elective coronary stenting
2014-001148-40Phase 3Active
- Sponsor
- Universitäts-Herzzentrum Freiburg-Bad Krozingen
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of clopidogrel and prasugrel in coronary arteriosclerosis (3 arms), sponsored by Universitäts-Herzzentrum Freiburg-Bad Krozingen. Started Apr 2014; status: active.
02
Drugs
clopidogrelprasugrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2014-001148-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001148-40.